One challenge is competition for remote staff is nationwide, says Kimberly Scaccia, VP of Revenue Management for Mercyhealth.
Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.
To get ROI, execs need to apply technology at scale, says former HCA CFO Bill Rutherford, who is now on the Board of Mangers at Ensemble Health Partners.
New U.S. Department of Labor rule would have an immediate positive effect on pharmacies and negatively impact the big Pharmacy Benefit Managers (PBMs), says Dae Y. Lee, attorney at Buchanan Ingersoll & Rooney.
